不知病因的口腔癌的分子景观
medRxiv : the preprint server for health sciences
|January 3, 2024
概括
年轻患者口腔癌 (OC) 的增加缺乏危险因素. 我们的研究揭示了这种新兴癌症亚型的独特分子驱动因素,包括内源性突变和微生物反应.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 分子生物学分子生物学
背景情况:
- 移动舌癌的发病率,一种口腔癌 (OC),在年轻患者中正在增加.
- 这种OC亚型缺乏已确定的风险因素 (NIRF),已确定的分子标记物和明显的临床识别.
研究的目的:
- 在年轻患者中研究没有确定的风险因素 (NIRF) 的口腔癌 (OC) 的分子特征.
- 了解这种新兴恶性瘤的独特疾病驱动因素和分子程序.
主要方法:
- 对公众头癌多组数据的分析.
- 鉴定突变特征以分层口腔癌 (OC) 和喉癌病例.
- 检查甲基组模式和抗微生物转录基因反应.
主要成果:
- 突变特征成功地分层了307个OC和109个喉癌病例.
- NIRF OCs显示内源性时钟状和APOBEC相关的突变性增加.
- 在NIRFOC中观察到不同的甲基组模式,特定的癌症驱动突变和抗菌药物反应.
- 在OC中突变特征SBS16与酒精和烟草使用相关.
结论:
- 这项研究描述了NIRFOCs独特的分子景观.
- 新出现的证据表明,内源性突变的增加和微生物侮辱反应驱动了这种癌症亚型.
- 这些发现为承认NIRF OCs作为一个独特的临床实体铺平了道路.
相关概念视频
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Cancers Originate from Somatic Mutations in a Single Cell
11.9K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.9K
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K


